ELGX Shares Outstanding History
Below is a table of the ELGX shares outstanding history going back to 2/10/2010:

Date ELGX Shares Outstanding
2/10/20104.87M
4/13/20104.87M
7/13/20104.90M
10/15/20104.90M
12/31/20105.64M
2/25/20115.60M
5/2/20115.68M
7/28/20115.75M
10/26/20115.76M
2/24/20125.82M
4/5/20125.77M
5/1/20125.82M
8/1/20126.14M
10/25/20126.20M
2/28/20136.27M
3/31/20136.28M
6/30/20136.31M
10/25/20136.35M
2/24/20146.39M
4/28/20146.40M
7/28/20146.70M
9/30/20146.70M
2/20/20156.72M
4/27/20156.74M
7/31/20156.78M
10/26/20156.78M
2/25/20168.17M
5/5/20168.18M
8/1/20168.24M
11/3/20168.27M
2/27/20178.29M
5/1/20178.30M
8/1/20178.34M
11/6/20178.35M
3/12/20188.37M
5/4/20188.40M
8/3/20188.47M
11/7/201810.35M
3/6/201910.35M
3/27/201910.35M
4/26/201916.77M
5/6/201916.79M
8/6/201917.61M
11/4/201917.94M
3/4/202019.09M
5/18/202019.17M

Also see: ELGX Market Cap History
ELGX YTD Return
ELGX Historical Shares Outstanding:
+14.28% CAGR
ELGX Historical Shares Outstanding: +14.28% CAGR

Mouse over chart for data details
2/10/2010 ...5/18/2020
Endologix develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. Co.'s products are designed for the endovascular treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: endovascular aneurysm repair (EVAR); or endovascular aneurysm sealing (EVAS), Co.'s solution for sealing the aneurysm sac while maintaining blood flow. Co.'s EVAR products include the AFX® Endovascular AAA System, the VELA® Proximal Endograft, and the Ovation® Abdominal Stent Graft System. Co.'s EVAS product is the Nellix® Endovascular Aneurysm Sealing System. We show 46 historical shares outstanding datapoints in our coverage of ELGX's shares outstanding history.

Understanding the changing numbers of ELGX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELGX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELGX by allowing them to research ELGX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ELGX:
ELGX SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Endologix (ELGX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ENDP Shares Outstanding History
ENSG Shares Outstanding History
ENTA Shares Outstanding History
ENZ Shares Outstanding History
EPZM Shares Outstanding History
ESPR Shares Outstanding History
ESRX Shares Outstanding History
EVFM Shares Outstanding History
EVHC Shares Outstanding History
EVOK Shares Outstanding History
More Healthcare companies »

 

ELGX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.